제품소개

제품 > 수출 의약품(인체)

new

Dacarbazin Inj.

  • 구분기타
  • 분류Antineoplastic
  • 약가0
  • 포장단위1 Vial /Box

주요정보

Indications & Usage
Metastatic malignant melanoma, Hodgkin's disease, neuroblastoma, soft-tissue sarcoma including leiomyosar-coma 

 

Dosage & administration
▷Malignant Melanoma: 2∼4.5 mg/kg/day for 10 days. Repeat at 4 week intervals.

▷Hodgkin's disease: 150 mg/m2/day for 5 days, in combination with other effective drugs. Repeat every 4 weeks.